ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļCLPT
āļāļ·āđāļāļāļĢāļīāļĐāļąāļClearpoint Neuro Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJul 03, 2019
āļāļĩāļāļĩāđāļBurnett (Joseph Michael)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ115
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJul 03
āļāļĩāđāļāļĒāļđāđ120 S. Sierra Avenue
āđāļĄāļ·āļāļSOLANA BEACH
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ92075
āđāļāļĢāļĻāļąāļāļāđ19499006833
āđāļ§āđāļāđāļāļāđhttps://www.clearpointneuro.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļCLPT
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJul 03, 2019
āļāļĩāļāļĩāđāļBurnett (Joseph Michael)
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Timothy T. Richards
Independent Director
Mr. Mazin Sabra
Chief Operating Officer
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Ms. Lynnette C. Fallon
Independent Director
Mr. Pascal E.R. Girin
Independent Director
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Mr. Danilo D' Alessandro
Chief Financial Officer
Dr. Linda M. Liau
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Timothy T. Richards
Independent Director
Mr. Mazin Sabra
Chief Operating Officer
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Ms. Lynnette C. Fallon
Independent Director
Mr. Pascal E.R. Girin
Independent Director
Invesco NASDAQ Future Gen 200 ETF
iShares Neuroscience and Healthcare ETF
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Vanguard US Momentum Factor ETF
Motley Fool Next Index ETF
Invesco Russell 2000 Dynamic Multifactor ETF
iShares Russell 2000 Growth ETF
Proshares Ultra Russell 2000
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Invesco NASDAQ Future Gen 200 ETF
āļŠāļąāļāļŠāđāļ§āļ1.19%
iShares Neuroscience and Healthcare ETF
āļŠāļąāļāļŠāđāļ§āļ0.94%
iShares Micro-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.09%
Vanguard US Momentum Factor ETF
āļŠāļąāļāļŠāđāļ§āļ0.06%
Motley Fool Next Index ETF
āļŠāļąāļāļŠāđāļ§āļ0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
āļŠāļąāļāļŠāđāļ§āļ0.03%
iShares Russell 2000 Growth ETF
āļŠāļąāļāļŠāđāļ§āļ0.03%
iShares Russell 2000 ETF
āļŠāļąāļāļŠāđāļ§āļ0.02%
Proshares Ultra Russell 2000
āļŠāļąāļāļŠāđāļ§āļ0.02%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ